Pearson, P A <br/><br/>
Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients.  [electronic resource] 

 -  Ophthalmology  Jan 1999 
 - 148-53 p.  digital 
<br/><br/> Publication Type: Case Reports; Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0161-6420 
<br/><br/><label>Standard No.: </label>10.1016/S0161-6420(99)90021-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antiprotozoal Agents--adverse effects<br/>Atovaquone<br/>Chorioretinitis--drug therapy<br/>Drug Evaluation<br/>Female<br/>Follow-Up Studies<br/>Fundus Oculi<br/>Humans<br/>Immunocompetence<br/>Middle Aged<br/>Naphthoquinones--adverse effects<br/>Prospective Studies<br/>Safety<br/>Toxoplasmosis, Ocular--drug therapy<br/>Treatment Outcome<br/>Visual Acuity